Related Experiment Videos
WldS mice are resistant to paclitaxel (taxol) neuropathy
Min Sheng Wang1, Albert A Davis, Deborah G Culver
1Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Abstract:
The WldS mouse is a unique mutant strain that demonstrates the remarkable phenotype of prolonged survival of transected axons ("slow Wallerian degeneration"). In these studies, we tested whether this neuroprotective phenotype extends to axonal degeneration seen in a progressive peripheral neuropathy. WldS and wild-type mice were intoxicated with the cancer chemotherapeutic agent paclitaxel (Taxol). The severity of the resultant sensory neuropathy was compared with behavioral, physiological, and pathological measures. WldS mice were resistant to paclitaxel neuropathy by all measures, and the resistance was because of protection against axonal degeneration. These studies demonstrate for the first time that the WldS mouse is more than a slow Wallerian degeneration phenotype, emphasizing the mechanistic link between Wallerian degeneration and peripheral neuropathy. Understanding how this mutant gene confers protection against axonal degeneration will provide important clues toward prevention of axonal degeneration in several human neurological disorders.
Insights
The WldS mouse, exhibiting slow Wallerian degeneration, shows resistance to paclitaxel-induced peripheral neuropathy. This highlights a protective mechanism against axonal degeneration, offering insights for neurological disorder prevention.
Area of Science:
- Neuroscience
- Genetics
- Toxicology
Background:
- The WldS mouse model exhibits prolonged axonal survival after transection, a phenomenon termed slow Wallerian degeneration.
- Axonal degeneration is a key pathological feature in various peripheral neuropathies.
Purpose of the Study:
- To investigate if the neuroprotective phenotype of WldS mice extends to paclitaxel-induced peripheral neuropathy.
- To explore the mechanistic link between Wallerian degeneration and chemotherapy-induced axonal damage.
Main Methods:
- WldS and wild-type mice were administered paclitaxel (Taxol) to induce sensory neuropathy.
- Neuropathy severity was assessed using behavioral, physiological, and pathological evaluations.
Main Results:
- WldS mice demonstrated significant resistance to paclitaxel-induced neuropathy across all measured parameters.
- This resistance was attributed to the WldS mutation conferring protection against axonal degeneration.
Conclusions:
- The WldS mouse model offers a valuable tool for studying mechanisms underlying peripheral neuropathy beyond Wallerian degeneration.
- Understanding the WldS neuroprotective mechanism may provide therapeutic strategies for preventing axonal degeneration in human neurological diseases.